Live Chat ×
Skip to main content

Placental Pathology - A Tour of Common and Rare Pathologies with a Focus on Clinical Relevance



Evaluated by: 
David B. Kaminsky, MD, FIAC, October 6, 2018
Original release date: November 19, 2018
Access to this course expires on:  October 6, 2021
CME 11
SAM 10.5

Course Description

The placenta provides a wealth of information, retrospectively about the fetus and prospectively regarding the infant. Its examination is an essential component of the autopsy in cases of fetal or infant death, often gives useful insights of the diagnosis and treatment of sick newborns, and reflects the impact of maternal disorders on pregnancy. Yet, most pathologists have had little or no education or training in the examination of the placenta, including its histologic appearance in health and disease, and particularly the range of appearances with gestational age. Pathological examination of the placenta is probably the most under-utilized pathologic assessment of any human tissue.  

This focused course provides the unique opportunity to learn from two experts in an intimate mentoring environment, and to close the practice gaps that reflect deficits in teaching and learning the extraordinary variants of placental pathology and how they relate clinically to infant and maternal management.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

  Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Enhance confidence in diagnosing and reporting clinically significant placental pathologies 
  • Enhance confidence in diagnosing and reporting gestational trophoblastic neoplasia
  • Understand the critical diagnoses that necessitate immediate reporting

  Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 10.5 SAM credit hours.

DisclosuresThe faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Theonia K. Boyd, MD, Drucilla J. Roberts, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must complete the evaluation. Your certificate will be available to view and print by clicking here.

Buy the entire Placental Pathology - A Tour of Common and Rare Pathologies with a Focus on Clinical Relevance and get a great discount!

Not A Member? Click Here